Genflow Biosciences plc (LON:GENF – Get Free Report) shares were up 22.6% during mid-day trading on Friday . The stock traded as high as GBX 1.98 and last traded at GBX 1.90. Approximately 4,466,838 shares were traded during trading, a decline of 13% from the average daily volume of 5,160,441 shares. The stock had previously closed at GBX 1.55.
Genflow Biosciences Stock Up 29.0%
The firm has a market cap of £9.87 million, a P/E ratio of -3.98 and a beta of 2.37. The firm has a fifty day moving average of GBX 1.82 and a 200-day moving average of GBX 1.15.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its quarterly earnings results on Tuesday, September 30th. The company reported GBX (0.19) earnings per share for the quarter. Genflow Biosciences had a net margin of 778.46% and a negative return on equity of 208.12%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Recommended Stories
- Five stocks we like better than Genflow Biosciences
- 3 Warren Buffett Stocks to Buy Now
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- The 3 Best Blue-Chip Stocks to Buy Now
- SoFi Technologies: From Fintech Speculation to Profit Engine
- How to Use the MarketBeat Excel Dividend Calculator
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
